Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

İsmail Hanta

5PUBLICATIONS

35CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Respiratory diseasesPharmaceutical delivery technologies

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (5)

Sort by Publication Date:

|Dec 31, 2025

Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes.

Pelin Duru Cetinkaya, Ozgecan Kayalar, Vahap Eldem

|Jul 30, 2025

Risk Factors and Biomarkers for Pulmonary Toxicities Associated with Immune Checkpoint Inhibitors.

Efraim Guzel, Ismail Hanta, Oya Baydar Toprak

|Feb 25, 2025

Association of TOLLIP mRNA Expression and TOLLIP rs5743899A/G, TOLLIP rs3750920C/T, and IL-10 -1082G/A Single-Nucleotide Polymorphisms with Susceptibility to Tuberculosis.

Togrul Nagiyev, Emel Eker, Ali Uckayabasi

|Aug 29, 2024

Comparative Transcriptomic Analyses of Peripheral Blood Mononuclear Cells of COVID-19 Patients without Pneumonia and with Severe Pneumonia in the First Year of Follow-Up.

Ozgecan Kayalar, Pelin Duru Cetinkaya, Vahap Eldem

|Sep 27, 2021

Evaluation of efficacy and safety of pirfenidone 200 mg tablets in patients with idiopathic pulmonary fibrosis in a real-life setting

Funda Coşkun, Aykut Çilli, İsmail Hanta

Pageof 1

Frequent Collaborators

3 joint publications

Oya Baydar Toprak

2 joint publications

Onder Ozturk

2 joint publications

Esra Nurlu Temel

2 joint publications

Aysegul Tomruk Erdem

2 joint publications

Ozgecan Kayalar

2 joint publications

Vahap Eldem

2 joint publications

Serap Argun Baris

2 joint publications

Nurdan Kokturk

2 joint publications

Hadi Rajabi

2 joint publications

Nur Konyalilar

Frequent Collaborators

3 joint publications

Oya Baydar Toprak

2 joint publications

Onder Ozturk

2 joint publications

Esra Nurlu Temel

2 joint publications

Aysegul Tomruk Erdem

Top Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on : Oct 14, 2021

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on : Apr 30, 2020

See more related videos

Top Related Videos

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on : Oct 14, 2021

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA)

Published on : Apr 30, 2020

See more related videos